Mr. López-Belmonte Encina graduated in Economic and Business Sciences, specialising in Auditing, from CEU San Pablo, Madrid in 1994. He is a shareholder of Norbel Inversiones, S.L., where he holds 33% of the share capital (this company is, in turn, ROVI’s controlling shareholder) and 2nd Deputy Chairman of ROVI’s Board of Directors. As part of his post-graduate education, in 2008 he earned a Diploma in Advanced Studies which qualifies him as an investigator in the fields of economics, finance and accounting. He began his professional career in Germany, working in companies like Amersham, engaged in nuclear medicine, and Hexal AG, specialised in generics. He has been working for the Company since 1995 and has been ROVI’s Chief Sales & Development Officer since September 2007. He was initially appointed to the Company’s Board of Directors on 27 July, 2007 when ROVI was first listed on the securities markets and was re-elected at the General Shareholders’ Meetings held on 2012, 2017 and 2021.

English
Read time: 1 min
Sub Title: 
2nd Vicepresident
Position: 
Executive
First Appointment: 
27 July, 2007
Latest Appointment: 
17 June, 2021
Other Boards of Directors: 
Company: 
NORBEL INVERSIONES, S.L.
Position / Partner: 
Director
Company: 
BERTEX
Position / Partner: 
Joint abd Several Administrator
Company: 
GLICOPEPTON BIOTECH, S.L.
Position / Partner: 
Chairman
Direct Voting: 
0
Indirect Voting: 
0
Total Voting: 
0